Peptide Science Glossary: 57 Terms From Synthesis, Testing, Storage and the Research Literature
Research use only. StarBio products are supplied strictly for in vitro laboratory research by qualified professionals. They are not for human or veterinary use, not for diagnostic or therapeutic use, and have not been evaluated by the FDA. This glossary defines chemistry, analysis, storage and literature terms only.
The research peptide glossary covers the words on a certificate, a vial label and a product page. This page covers the vocabulary behind them: how a peptide is made, what a wider test panel can include, what happens to material in storage, and the terms that recur in the papers cited on compound pages. Definitions are kept short and factual. Nothing here is a method or an instruction.
How peptides are made
Peptide synthesis. Building a peptide chemically, one amino acid at a time, in a defined order. Research peptides are almost always made this way and not extracted from tissue. The sequence, and therefore the expected mass, is fixed by the order of additions.
Solid-phase peptide synthesis (SPPS). The standard method, introduced by Bruce Merrifield in 1963. The first amino acid is anchored to an insoluble support and the chain is extended from the C-terminus toward the N-terminus. Because the growing chain stays attached to the support, excess reagents are simply washed away after each step.
Fmoc chemistry. The most common SPPS scheme. Each incoming amino acid carries a 9-fluorenylmethoxycarbonyl (Fmoc) group on its amine so that it can only react once. The group is removed with a mild base before the next amino acid is added.
Resin. The insoluble polymer beads a peptide is built on during solid-phase synthesis. The choice of resin decides whether the finished chain ends in a free acid or in a C-terminal amide.
Coupling and deprotection. The two steps repeated for every residue: deprotection exposes the amine at the end of the chain, coupling attaches the next amino acid to it. A 29-residue peptide needs 28 such cycles after the first residue is loaded.
Cleavage. The final step of synthesis, in which strong acid (usually trifluoroacetic acid) releases the finished chain from the resin and removes the protecting groups on the side chains. It is the reason a freshly made peptide starts life as a trifluoroacetate salt. See acetate, TFA and net peptide content.
Crude peptide. The material straight after cleavage, before purification. It contains the target sequence together with the by-products of every imperfect step.
Preparative HPLC. Liquid chromatography run at large scale to purify, not to measure. The fraction containing the target peptide is collected and the rest discarded. Analytical HPLC, the kind reported on a certificate, then checks how well that worked.
Deletion and truncated sequences. The typical synthesis impurities. A deletion sequence is missing one residue because a coupling did not go to completion; a truncated sequence stopped growing early. Both resemble the target closely, which is why they are the small peaks next to the main peak on a chromatogram.
Counter-ion (counterion). The oppositely charged ion that accompanies a charged peptide in the solid: acetate, trifluoroacetate or chloride. It is part of the powder’s weight and invisible to an HPLC purity test. See net peptide content.
Lyophilization (freeze-drying). The process that turns a purified peptide solution into a dry solid. The solution is frozen, then the ice is removed as vapour under vacuum without passing through liquid water. The product of the process is described as lyophilized.
Excipient (bulking agent, filler). Any substance in a vial other than the compound itself. Mannitol is the common bulking agent in freeze-dried material: it gives a few milligrams of peptide a visible, solid cake. An excipient adds weight and volume, has no ultraviolet absorbance, and so does not appear in an HPLC purity figure.
Fill weight and overfill. Fill weight is the amount of material actually dispensed into a vial. Overfill is a deliberate margin above the labelled amount. A certificate that reports measured content shows where a given lot landed against its label.
On a wider test panel
A laboratory tests what it is asked to test. Purity, identity and content are the usual panel for a research peptide; the analyses below are separate orders. A certificate that does not list one of them did not measure it. Background: the independent testing ecosystem.
LC-MS. Liquid chromatography coupled directly to mass spectrometry. Each peak leaving the column is weighed as it emerges, so a single run reports both how much of each component is present and what its mass is. See HPLC and mass spectrometry.
Assay. In analytical chemistry, a measurement of how much of a substance is present. Purity asks what fraction of the detected material is the target; assay asks how many milligrams of the target are there. The two figures answer different questions.
Reference standard. A sample of known identity and content that an unknown is measured against. Running one alongside a test sample lets the laboratory match retention times and convert a peak area into a quantity.
Amino acid analysis. A method that breaks a peptide down into its individual amino acids with hot acid and measures each one. It confirms the composition and gives the most direct figure for net peptide content.
Water content (Karl Fischer). The share of a powder’s weight that is water, measured by Karl Fischer titration. Freeze-dried peptides normally retain a few percent.
Residual solvents. Traces of the organic liquids used in synthesis and purification, such as acetonitrile, that remain after drying. Measured by gas chromatography.
Endotoxin. Lipopolysaccharide from the outer membrane of Gram-negative bacteria. It is heat-stable and passes through sterilising filters, so a material can be sterile and still carry endotoxin. It matters in cell culture because cells respond to very small amounts. Reported in endotoxin units (EU).
LAL test. The Limulus amebocyte lysate test, the standard endotoxin assay. A reagent prepared from horseshoe crab blood cells clots or changes colour in the presence of endotoxin. Recombinant reagents that avoid the animal source are also in use.
Bioburden. The number of living microorganisms on or in a material, counted as colony-forming units (CFU). A count, where a sterility test is a pass or fail.
Sterility test. A test in which a sample is incubated in growth media, typically for 14 days, and checked for microbial growth. Passing shows that nothing grew from the portion tested.
Heavy metals. Elemental impurities such as lead, cadmium, arsenic and mercury, measured by inductively coupled plasma mass spectrometry (ICP-MS).
Storage and stability
Peptide storage. The conditions a compound is kept under between manufacture and use: temperature, light and moisture. Each StarBio product page prints a storage line for that compound, and the reasoning is set out in storing lyophilized research peptides.
Shelf life. The period over which a material is expected to stay within its specification under stated storage conditions. It is a property of the conditions as much as of the compound: the same peptide lasts far longer dry and frozen than in solution.
Retest date and expiry date. Two different promises. A retest date is the point after which a material should be analysed again before it is relied on. An expiry date is the point after which it should not be used. Research materials are more often given a test date and a storage line than either.
Hygroscopic. Tending to absorb water from the air. Lyophilized peptides are hygroscopic, small and basic ones most of all, which is why vials are sealed and why a cake can change appearance once opened.
Desiccant. A drying agent, usually a sachet of silica gel, placed with stored material to keep the surrounding air dry.
Solubility. How readily a compound dissolves in a given liquid. For peptides it follows from the sequence: chains rich in charged residues dissolve easily in water, hydrophobic ones do not. Each compound guide notes where a compound is unusual in this respect.
Oxidation. A common route of peptide degradation in which a residue gains oxygen. Methionine is the most sensitive: it converts to methionine sulfoxide, which adds 16 Da and shows up as a separate peak. Sequences containing methionine, such as Semax and MOTS-c, are the ones where this is watched for.
Deamidation. The slow conversion of an asparagine (less often glutamine) side chain into an acid. It changes the mass by about 1 Da and happens faster in solution and at higher pH.
Aggregation. Peptide molecules sticking to one another to form larger, sometimes insoluble, assemblies. It can show as cloudiness in a solution or as a loss of the main peak.
In the research literature
These terms appear in the titles and abstracts of the papers listed under Sources and References on compound pages. They are defined here so the citations can be read, not to describe any use of a product.
Amino acid. The building block of peptides and proteins. Twenty are standard. Natural amino acids are the L-form; a “D-” prefix in a sequence, as in the D-phenylalanine of Melanotan I, marks the mirror-image form, introduced deliberately to change a peptide’s properties.
Peptide bond. The amide link between the carboxyl group of one amino acid and the amine of the next. Forming it releases one molecule of water, which is why a peptide weighs 18 Da less per bond than the sum of its amino acids.
Oligopeptide, polypeptide, protein. Size classes without sharp borders. An oligopeptide has from two to about twenty residues, a polypeptide more, and a protein is a long chain, conventionally above about fifty residues, that folds into a defined shape.
Peptide hormone. A hormone that is a peptide, as opposed to a steroid or an amine. Growth hormone-releasing hormone, the parent sequence of sermorelin, is one example.
Neuropeptide. A peptide made and released by nerve cells as a signalling molecule. Vasoactive intestinal peptide (VIP) and delta sleep-inducing peptide (DSIP) are described this way in the literature.
Signal peptide. A short stretch at the start of a newly made protein that directs it to the cell’s secretory pathway and is then cut off. A term from cell biology; it does not mean “a peptide that signals”.
Antimicrobial peptide. A member of a broad class of short, usually positively charged peptides that organisms produce as part of their defence against microbes. Studied in microbiology and immunology.
Receptor, agonist, antagonist. A receptor is the protein a signalling molecule binds to. An agonist binds and activates it; an antagonist binds and blocks it. Compound guides use these words when summarising what a paper reported.
GHRH and GHRH analogue. Growth hormone-releasing hormone is a 44-residue hypothalamic peptide. Its first 29 residues carry its activity: sermorelin is exactly that fragment, CJC-1295 is a modified version of it, and Tesamorelin is the full 44-residue sequence with a group added at its N-terminus. Compared in sermorelin vs CJC-1295 vs tesamorelin.
Growth hormone secretagogue (GHS, GHRP). A compound that acts at the ghrelin receptor, also written GHS-R1a. The growth hormone-releasing peptides (GHRPs) are the synthetic family first described at this receptor; ipamorelin, a pentapeptide, is a later compound that acts at the same receptor. A different receptor from the one GHRH analogues bind.
Drug affinity complex (DAC). A chemical group attached to a peptide so that it binds to albumin. “CJC-1295 with DAC” carries it; the “no DAC” form, also called modified GRF(1-29), does not. StarBio lists the no-DAC form, in a blend with ipamorelin.
Melanocortin receptors (MC1R to MC5R). A family of five receptors whose natural ligand is alpha-melanocyte-stimulating hormone (alpha-MSH). MC1R and MC4R are the two most often named in the literature on Melanotan II and PT-141, both of which are alpha-MSH analogues. Compared in Melanotan I vs Melanotan II vs PT-141.
Mitochondrial-derived peptide. A peptide encoded in mitochondrial DNA, not in the cell nucleus. MOTS-c, a 16-residue peptide encoded within the 12S rRNA gene, is the example in the catalogue.
Bioregulator peptide. The name used in one body of literature, largely from St Petersburg, for very short peptides of two to four residues. Epithalon (AEDG), Pinealon (EDR) and Cartalax (AED) belong to it.
Thymic peptide. A peptide first isolated from thymus tissue. Thymosin alpha-1, a 28-residue peptide, is one; thymosin beta-4, the parent of the TB-500 fragment, was found in the same extracts.
In vitro, in vivo, preclinical. In vitro means in glass: work on cells, tissue or isolated molecules outside a living organism. In vivo means within a living organism. Preclinical covers both when done before any study in people. StarBio materials are sold for in vitro work only.
Cell culture. Growing cells outside an organism under controlled conditions. The setting for most in vitro peptide work, and the reason endotoxin and sterility come up.
Animal model. A laboratory animal study designed to reproduce some aspect of biology or disease. Much of the cited literature for catalogue compounds reports animal models; a paper’s title usually says which species.
Half-life. The time taken for the amount of a compound to fall by half. Quoted in papers for a compound in solution, in a medium or in circulation; the context decides which.
Pharmacokinetics. The study of how a compound’s concentration changes over time in an organism: absorption, distribution, metabolism and excretion. A term from published studies, not a description of StarBio documentation.
Cytokine. A small signalling protein released by cells, especially immune cells. Often what a cell-based experiment measures.
NNMT. Nicotinamide N-methyltransferase, an enzyme that methylates nicotinamide. 5-Amino-1MQ is studied as an inhibitor of it.
Sirtuin. One of a family of enzymes (SIRT1 to SIRT7 in mammals) that depend on NAD+ to work. The link explains why the two words appear together in the literature.
Telomerase. The enzyme that extends telomeres, the repeated sequences at the ends of chromosomes. Epithalon is studied in cell and animal models of telomerase activity.
Using this page
Every term has an anchor, so another page can link straight to a definition (for example #endotoxin). Certificate, label and catalogue terms are in the research peptide glossary. StarBio’s current laboratory reports are in the COA library.
For laboratory research use only. Not for human or veterinary use.
New reports and guides, by email
A short note when a new laboratory report is published, when a compound returns to stock, and when a new guide goes up. Nothing else. Leave whenever you like.
For laboratory research use only. No dosing or protocol content is ever sent.

